Cytosorbents Corp
CTSO
27 hedge funds and large institutions have $11.9M invested in Cytosorbents Corp in 2015 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
950% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 2
205% more capital invested
Capital invested by funds: $3.92M → $11.9M (+$8.02M)
200% more funds holding
Funds holding: 9 → 27 (+18)
4% more call options, than puts
Call options by funds: $230K | Put options by funds: $222K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.55M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.31M |
| 3 |
AIG
American International Group
New York
|
+$899K |
| 4 |
Millennium Management
New York
|
+$523K |
| 5 |
Morgan Stanley
New York
|
+$493K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Signet Financial Management
Parsippany,
New Jersey
|
-$2.87M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$8K |
CTSO Hedge Fund Activity: Q1 2015 in Review
27 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2015, worth a combined $11.9M — up 205% from $3.92M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new CTSO positions and 2 closed out — a net gain of 19 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $2.55M. The largest seller was Signet Financial Management, exiting entirely with an estimated $2.87M sold.
- 27 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2015, up from 9 in Q4 2014.
- Funds reported $11.9M of Cytosorbents Corp stock for Q1 2015, up 205% quarter-over-quarter.
- 21 funds opened new Cytosorbents Corp positions in Q1 2015 and 2 closed out, a net change of +19 holders.
- The largest Cytosorbents Corp buyer in Q1 2015 was Vanguard Group, an estimated $2.55M added.
- The largest Cytosorbents Corp seller in Q1 2015 was Signet Financial Management, an estimated $2.87M sold.
Based on aggregated 13F filings for Q1 2015.